Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Phio Pharmaceuticals Corp (NQ: PHIO ) 0.6850 -0.0279 (-3.91%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Phio Pharmaceuticals Corp Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging June 18, 2024 Phio's Compound RXI-185 is designed to slow progression of UV induced collagen breakdownMarlborough, Massachusetts--(Newsfile Corp. - June 18, 2024) -... Via Newsfile Topics Intellectual Property Exposures Intellectual Property Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 May 28, 2024 Intratumoral PH-762 has encouraging safety profile in the initial cohortEscalation to proceed to next dose concentrationMarlborough, Massachusetts--(Newsfile Corp. - May... Via Newsfile Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) May 23, 2024 Marlborough, Massachusetts--(Newsfile Corp. - May 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary... Via Newsfile Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update May 09, 2024 From Phio Pharmaceuticals Corp. Via GlobeNewswire Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update April 02, 2024 From Phio Pharmaceuticals Corp. Via GlobeNewswire Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update November 09, 2023 From Phio Pharmaceuticals Corp. Via GlobeNewswire Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 From Phio Pharmaceuticals Corp. Via GlobeNewswire Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Near the Top of Equities by Percentage Gain on 4/18 April 18, 2023 Via Investor Brand Network Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D September 17, 2021 Via FinancialNewsMedia Topics Death Exposures Death Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.